The Weekly Litigation News Digest is now live. Subscribe now

Animal Models And Therapeutic Molecules - EP2798950

The patent EP2798950 was granted to Kymab on Mar 22, 2023. The application was originally filed on Jul 7, 2010 under application number EP14170196A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2798950

KYMAB
Application Number
EP14170196A
Filing Date
Jul 7, 2010
Status
Patent Maintained As Amended
Feb 17, 2023
Publication Date
Mar 22, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

REGENERON PHARMACEUTICALSJan 18, 2018J A KEMPADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5859307
DESCRIPTIONWO0104288
DESCRIPTIONWO2007117410
DESCRIPTIONWO2010039900
DESCRIPTIONWO9929837
OPPOSITIONEP2480676
OPPOSITIONUS6596541
OPPOSITIONUS7294754
OPPOSITIONWO02066630
OPPOSITIONWO2011163314
SEARCHUS2006015957
SEARCHWO02066630
SEARCHWO2007117410
SEARCHWO2008070367
SEARCHWO2011163311

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents